← Leaderboards
James V Alvarez
Fred Hutchinson Cancer Center
$5,685,964
Attributed
$6,811,042
Total exposure
4
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.2M · FY2016–25$2M$1.5M$1M$500K$0
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$6,811,042 · 4
By mechanism
R01$6,811,042 · 4
Top collaborators
- Nimmi Ramanujam4 shared
Most similar at Fred Hutchinson Cancer Center
Same institution · by research overlap
- Nina Reda Salama$17,035,927
Others in their field
Top investigators on “Recurrence”
- Philip J Disaia · University Of California Irvine$95,481,777
- David Heimbrook · Leidos Biomedical Research, Inc.$87,033,539
- Wafaa M. El-Sadr · Columbia University Health Sciences$84,793,830
- Myron S Cohen · Family Health International$84,793,830
- Lawrence Corey · Fred Hutchinson Cancer Center$59,594,035
- Dan H. Barouch · Fred Hutchinson Cancer Center$59,594,035
Research focus
RecurrencePathway InteractionsMalignant NeoplasmsMalignant Breast NeoplasmCellsNeoplastic CellTumorRecurrent TumorBreast Cancer ModelGenetically Engineered MouseDown-RegulationExhibitsRecurrent DiseaseSamplingSignal TransductionPublishingDistantGenetic TranscriptionInsightCessation Of LifeBreast Cancer CellPreventCancer RecurrenceCause Of Death
Grant awards (16)
Par-4 Regulation of Actomyosin Contractility as a Tumor Suppressive Mechanism in Breast Cancer$615,796
R01 · FY2025 · CA · contact PI
NRF2 suppression of inflammatory signaling and its role in tumor progression$601,353
R01 · FY2025 · CA · contact PI
Par-4 Regulation of Actomyosin Contractility as a Tumor Suppressive Mechanism in Breast Cancer$625,273
R01 · FY2024 · CA · contact PI
NRF2 suppression of inflammatory signaling and its role in tumor progression$597,119
R01 · FY2024 · CA · contact PI
A Portable low-cost, Point of Investigation CapCell Scope to Image and Quantify the Major Axes of Metabolism and the Associated Vasculature in In vitro and In vivo Biological Models$565,303
R01 · FY2022 · EB
A Portable low-cost, Point of Investigation CapCell Scope to Image and Quantify the Major Axes of Metabolism and the Associated Vasculature in In vitro and In vivo Biological Models$563,937
R01 · FY2021 · EB
A Portable low-cost, Point of Investigation CapCell Scope to Image and Quantify the Major Axes of Metabolism and the Associated Vasculature in In vitro and In vivo Biological Models$576,841
R01 · FY2020 · EB
Par-4 Regulation and Function in Breast Cancer Dormancy and Recurrence$287,086
R01 · FY2020 · CA · contact PI
Par-4 Regulation and Function in Breast Cancer Dormancy and Recurrence$61,196
R01 · FY2020 · CA · contact PI
Par-4 Regulation and Function in Breast Cancer Dormancy and Recurrence$17,938
R01 · FY2020 · CA · contact PI
A Portable low-cost, Point of Investigation CapCell Scope to Image and Quantify the Major Axes of Metabolism and the Associated Vasculature in In vitro and In vivo Biological Models$544,076
R01 · FY2019 · EB
Par-4 Regulation and Function in Breast Cancer Dormancy and Recurrence$440,092
R01 · FY2019 · CA · contact PI
Par-4 Regulation and Function in Breast Cancer Dormancy and Recurrence$363,713
R01 · FY2018 · CA · contact PI
Par-4 Regulation and Function in Breast Cancer Dormancy and Recurrence$223,893
R01 · FY2018 · CA · contact PI
Par-4 Regulation and Function in Breast Cancer Dormancy and Recurrence$363,713
R01 · FY2017 · CA · contact PI
Par-4 Regulation and Function in Breast Cancer Dormancy and Recurrence$363,713
R01 · FY2016 · CA · contact PI